ODESSA, Texas (Nexstar) – The medical center hospital, along with the Odessa Regional Medical Center, held a press conference on Monday to inform the community of hospitalizations for coronavirus.
MCH spoke specifically of two changes within the hospital amid a lower COVID-19 patient census.
On Monday, the MCH said it resumed elective surgeries for patients who do not need an overnight stay in the hospital. At this time, the hospital does not schedule elective surgeries for anyone who may need an overnight stay; the hospital says it will reassess that decision in two weeks.
The second change concerns extended visits for non-coronavirus patients treated in the intensive care unit. Starting Tuesday, patients who test negative for the virus will be allowed to have visitors from 10:00 a.m. to 10:00 p.m. Patients will still be limited to one visitor per day and all visitors will be required to mask themselves and be asked screening questions. when arriving at the hospital. For COVID-19 CCU patients, the MCH says visiting hours will remain limited to 1:00 p.m. to 3:00 p.m. for now.
On Monday, the MCH said it was caring for 87 patients with the virus; however, over the weekend, the hospital saw its coronavirus census plunge into the 1970s. Of those hospitalized, 28 patients are ventilated. The patients are between 16 and 89 years old.
The ORMC says it takes care of 23 patients infected with the virus, 9 of whom are ventilated. ORMC patients range from 30 to 70 years old, depending on the hospital.
Both hospitals say most hospital patients are not vaccinated. This statistic held true throughout the most recent outbreak. Now, the city of Odessa and its partners are preparing to vaccinate anyone looking for a vaccine.
The drive-thru vaccination clinic will begin Tuesday and will run from 9 a.m. to 1 p.m. Tuesday to Friday for the next several weeks. Workers will administer the first and second doses of Pfizer and Moderna vaccines. The city says booster shots will be available to anyone with a doctor’s note.
Regarding vaccines, ORMC chief medical officer Dr Rohith Saravanan said today that Pfizer has released data indicating that the vaccine is effective in children aged 5 to 11. Now the FDA will review the data and should decide whether or not to grant emergency clearance to children in this age group. At this time, vaccines are only approved for children over 12 years old.